best provider for tirzepatide (Month 1) 2.5mg Tirzepatide 10mg – Dual GIP/GLP-1

Long-term safety data are still being gathered, and the full safety profile of retatrutide has not yet been established

A network meta-analysis of 22 RCTs of 2,258 participants found that lean mass accounted for roughly 25% of total weight lost on GLP-1 drugs, and DXA body-composition substudies report a range of 2640%

PMID: 9821131 Hobbs WR, Sponseller PD, Weiss AP, Pyeritz RE

Medicare Coverage Limitations Medicare does not cover medications used solely for weight loss

Variants in GLP1R, GIPR, and metabolic genes like FTO can support a more personalized discussion about which medication formulation or dosing protocol may be worth exploring with your provider

The same standard used for vaccine transport